Hong Kong to Receive Sinovac, Pfizer-BioNTech COVID-19 Vaccines in Q1



[ad_1]

HONG KONG: Hong Kong ordered 15 million doses of the COVID-19 vaccine, split between China’s Sinovac Biotech and Pfizer-BioNTech, twice as many residents, city leader Carrie Lam said on Friday (December 11). .

The first batch of 1 million will arrive from China in January, while another million from Pfizer-BioNTech will be delivered in the first quarter of next year.

READ: Singapore and Hong Kong to postpone launch of air travel bubble

The government is targeting 30 million doses in total, as each person needs two injections to be fully vaccinated, and is also in talks to buy the Oxford-AstraZeneca vaccine. The latter is expected to arrive in the second half of next year.

Priority will be given to the elderly and other vulnerable categories, Lam said.

The former British colony has avoided the large outbreaks seen in other major cities around the world, reporting around 7,300 cases since January, with 114 deaths.

CHECK THIS: Our comprehensive coverage of the coronavirus outbreak and its developments

Download our app or subscribe to our Telegram channel for the latest updates on the coronavirus outbreak: https://cna.asia/telegram

[ad_2]